ArticleInfectious diseases and therapy2024

Patient-Reported Outcomes in COVID-19 Treatment with Monoclonal Antibodies Reveal Benefits in Return to Usual Activities.

Diana Rofail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.